1. Home
  2. TBBK vs NVCR Comparison

TBBK vs NVCR Comparison

Compare TBBK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

HOLD

Current Price

$69.50

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.50

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBBK
NVCR
Founded
1999
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
1.5B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
TBBK
NVCR
Price
$69.50
$14.50
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$69.33
$28.42
AVG Volume (30 Days)
659.5K
1.4M
Earning Date
01-29-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
21.10
N/A
EPS
4.78
N/A
Revenue
$523,163,000.00
$642,269,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$7.37
$5.62
P/E Ratio
$14.51
N/A
Revenue Growth
10.84
11.17
52 Week Low
$40.51
$10.70
52 Week High
$81.65
$29.80

Technical Indicators

Market Signals
Indicator
TBBK
NVCR
Relative Strength Index (RSI) 56.67 67.00
Support Level $66.06 $12.88
Resistance Level $70.56 $13.64
Average True Range (ATR) 1.77 0.50
MACD -0.04 0.12
Stochastic Oscillator 57.07 93.10

Price Performance

Historical Comparison
TBBK
NVCR

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: